G. Constantine

发表

Efficacy and safety of etodolac and naproxen in patients with osteoarthritis of the knee: a double-blind, placebo-controlled study.

R. Dore, I. Ballard, G. Constantine, 1995, Clinical therapeutics.

Double-blind, placebo-controlled comparison of the safety and efficacy of orally administered etodolac and nabumetone in patients with active osteoarthritis of the knee.

T. Schnitzer, I. Ballard, G. Constantine, 1995, Clinical therapeutics.

Randomized placebo- and active-controlled study of desvenlafaxine for menopausal vasomotor symptoms

N. Panay, W. Bao, P. Vincendon, 2012, Climacteric : the journal of the International Menopause Society.

Is sertraline treatment or depression remission in depressed Alzheimer’s patients associated with improved caregiver wellbeing? The Depression in Alzheimer’s Disease Study 2 (DIADS-2)

L. Schneider, P. Rabins, C. Meinert, 2014 .

Latent classes of neuropsychiatric symptoms in NACC controls and conversion to MCI or dementia

Jeannie-Marie S. Leoutsakos, Gwenn S. Smith, J. Leoutsakos, 2015 .

Effect of desvenlafaxine on mood and climacteric symptoms in menopausal women with moderate to severe vasomotor symptoms

D. Archer, W. Bao, J. Pickar, 2012, Climacteric : the journal of the International Menopause Society.

Nodular regenerative hyperplasia in X-linked agammaglobulinemia: an underestimated and severe complication.

S. Holland, D. Kleiner, G. Uzel, 2021, The Journal of allergy and clinical immunology.

Etodolac (Lodine) in the treatment of osteoarthritis: recent studies.

T. Schnitzer, G. Constantine, 1997, The Journal of rheumatology. Supplement.

Desvenlafaxine succinate (DVS) results in a sustained reduction in number of moderate-to-severe hot flushes (HFs)

L. Kirby, S. Olivier, K. Muse, 2007 .

A double-masked comparison of Naprelan and nabumetone in osteoarthritis of the knee. Naprelan Study Group.

R. Fleischmann, G. Constantine, B. Kolecki, 1997, Clinical therapeutics.